Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Questex Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Questex Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Vir Biotechnology
Biotech
HHS preps for pandemics, doles out $55M to Vir for flu mAb
HHS has granted Vir Biotechnology a multiyear contract and the chance to make up to $1 billion in efforts to prepare for public health emergencies.
Gabrielle Masson
Oct 4, 2022 3:05pm
Agios replaces CEO after recent FDA nod—Chutes & Ladders
Jul 15, 2022 9:30am
Alnylam ditches COVID-19 antiviral, citing effective vaccines
Aug 3, 2021 11:25am
Vir, GSK unveil final data for COVID-19 antibody
Jun 21, 2021 9:30am
EMA starts review of GSK and Vir's COVID-19 antibody therapy
Apr 16, 2021 8:55am
Vir, GSK race COVID-19 antibody to FDA for emergency nod
Mar 26, 2021 10:00am
